SOURCE: Hansen Medical, Inc.

November 25, 2008 14:51 ET

Hansen Medical to Present at Upcoming Investor Conferences

MOUNTAIN VIEW, CA--(Marketwire - November 25, 2008) - Hansen Medical, Inc. (NASDAQ: HNSN) announced today that it will be participating in upcoming investor conferences.

The company will be presenting at the 20th Annual Piper Jaffray Healthcare Conference being held December 2-3, 2008 at the New York Palace Hotel. Chief Financial Officer, Steve Van Dick, will provide a general company overview on Wednesday, December 3, 2008 at 4:00 p.m. Eastern.

The company will also be presenting at the JPMorgan Tenth SMid Cap Conference being held December 4-5, 2008 at the JPMorgan Conference Center in New York City. President and Chief Operating Officer, Gary Restani, will provide a general company overview on Friday, December 5, 2008 at 11:00 a.m. Eastern.

Hansen Medical will provide live audio webcasts of each presentation. Interested parties may access the live webcasts by visiting the investor relations section of Hansen Medical's web site at A replay of the webcasts will be available at the site after the live presentation.

About Hansen Medical, Inc.

Hansen Medical, Inc., based in Mountain View, Calif., develops products and technology using robotics for the accurate positioning, manipulation and control of catheters and catheter-based technologies. Its first product, the Sensei™ Robotic Catheter system, is a robotic navigation system that enables clinicians to place mapping catheters in hard-to-reach anatomical locations within the heart easily, accurately and with stability during complex cardiac arrhythmia procedures. The Sensei system is compatible with fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram data and was cleared by the U.S. Food and Drug Administration (FDA) in May 2007 for manipulation and control of certain mapping catheters in Electrophysiology (EP) procedures. The safety and effectiveness of the Sensei system for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including atrial fibrillation (AF), have not been established. In the European Union, the Sensei system is cleared for use during EP procedures, such as guiding catheters in the treatment of AF. Additional information can be found at

Contact Information